BMS takes AstraZeneca to court over cancer treatment

01-08-2017

BMS takes AstraZeneca to court over cancer treatment

CIPhotos / iStockphoto.com

Bristol-Myers Squibb (BMS) has taken AstraZeneca to court over the alleged infringement of a patent for cancer treatment.


Bristol-Myers Squibb, BMS, AstraZeneca, patent, patent infringement, cancer, oncology,

LSIPR